← Browse by Condition
Medical Condition

endometriosis related pain

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2

Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.

Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.

Frequently Asked Questions — endometriosis related pain Clinical Trials

How many clinical trials are currently recruiting for endometriosis related pain?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for endometriosis related pain, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for endometriosis related pain?
endometriosis related pain research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a endometriosis related pain clinical trial?
Eligibility criteria for endometriosis related pain trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Changchun GeneScience Pharmaceutical Co., Ltd. 1 trial
Sunnybrook Health Sciences Centre 1 trial
Göteborg University 1 trial

Recruiting Clinical Trials

NCT06963177 Phase 2
Recruiting

A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain

Enrollment
200 pts
Location
China
Sponsor
Changchun GeneScience Pharmace...
View Trial →
NCT06579040
Recruiting

The HEROES Trial: Hyperbaric Oxygen Therapy for Endometriosis-Related Pain

Enrollment
64 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT05152264
Recruiting

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

Enrollment
40 pts
Location
Sweden
Sponsor
Göteborg University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology